Le Lézard
Classified in: Health, Business
Subjects: PDT, LIC, BFA, CXP, MAT

DermCare Management Expands with New Partnerships in the Greater Dallas Area


HOLLYWOOD, Fla., May 6, 2024 /PRNewswire/ -- DermCare Management, a leader in specialized dermatology and cosmetic surgery practice management services, proudly announces two new practice acquisitions in Texas, bringing the total number of practice locations to 70.

"We've seen great success in Texas and look forward to continuing to grow with new partners who share our commitment"

DermCare Management welcomes Dr. Christine Brown Dermatology and Dr. Kim Dermatology to the DermCare family of Texas dermatology practices. Joining Dermatology Treatment and Research Center in Dallas, TX, and Stone Oak Dermatology in San Antonio, TX,  these two newly acquired practices further cement DermCare Management's commitment to supporting exceptional patient care in the Lone Star state. Both Dr. Christine Brown and Dr. Kim Werner Billet bring a wealth of knowledge and specialized experience to DermCare Management.

Dr. Brown is highly accomplished, receiving the prestigious American Medical Association Physician Recognition Award in Continuing Medical Education, and the AAD Continuing Medical Education Award. Texas Monthly has recognized her dedication to care, naming her to their annual Super Doctors® list for the last 10 years.

Dr. Kim Werner Billet has practiced dermatology for over 14 years. A military veteran, Dr. Billet completed her Dermatology residency at the San Antonio Uniformed Services Health Education Consortium, providing medical and surgical care to soldiers, retirees, and their dependents at several U.S. Army bases nationwide before honorably concluding her career in the military. Both women-led dermatology practices share a dedication to exceptional patient care which aligns with DermCare's central mission.

Jeffrey Schillinger, CEO of DermCare Management, expressed his enthusiasm, stating, "We've seen great success in Texas and look forward to continuing to grow with new partners who share our commitment to exceptional patient care. We invite any private practice dermatologist looking to leverage our business management expertise and solidify their presence in their community to connect with DermCare Management to learn about our personalized support services and partnerships."

ABOUT DERMCARE MANAGEMENT

DermCare Management, a portfolio company of Hildred Capital Management, is a dermatology practice management company founded on the principle of merging seasoned medical professionals with clinically focused management expertise. Established in 2017 with a group of 5 founding practices, DermCare continues its upward trajectory, now managing medical practices with approximately 150 providers across multiple states.

Media Contact: Ingrid Bennett, [email protected], 919-395-3956

SOURCE Dermcare Management


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: